Literature DB >> 11465411

Physicochemical parameters responsible for the affinity of methotrexate analogs for rat canalicular multispecific organic anion transporter (cMOAT/MRP2).

Y H Han1, Y Kato, M Haramura, M Ohta, H Matsuoka, Y Sugiyama.   

Abstract

PURPOSE: Canalicular multispecific organic anion transporter (cMOAT/MRP2) is known to exhibit a broad substrate specificity toward amphiphatic organic anions, including methotrexate (MTX). The present study aims to identify the physicochemical properties of MTX derivatives that correlate with recognition specificity by cMOAT/MRP2.
METHODS: We examined the inhibitory effect of MTX and 24 analogs on the transport of [3H]-S-(2,4-dinitrophenyl)glutathione by cMOAT/MRP2. The affinity constants of these compounds were compared with their physicochemical parameters. The primary active transport of several compounds was also confirmed.
RESULTS: The affinity constants closely correlated with the octanol/water partition coefficient (clogP), and a linear combination of polar and nonpolar surface areas. The affinity for cMOAT/MRP2 also closely correlated with the molecular weight, which also showed a significant correlation with nonpolar surface area and clogP.
CONCLUSIONS: Recognition by cMOAT/MRP2 depends on a balance of dynamic surface properties between the polar and nonpolar regions of MTX analogs. The so-called "molecular weight threshold" for the cMOAT/MRP2 affinity of these compounds can be explained by their physicochemical parameters, especially their nonpolar surface areas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465411     DOI: 10.1023/a:1011064806507

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Molecular volumes and surfaces of biomacromolecules via GEPOL: a fast and efficient algorithm.

Authors:  E Silla; F Villar; O Nilsson; J L Pascual-Ahuir; O Tapia
Journal:  J Mol Graph       Date:  1990-09

2.  Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.

Authors:  K Palm; K Luthman; A L Ungell; G Strandlund; F Beigi; P Lundahl; P Artursson
Journal:  J Med Chem       Date:  1998-12-31       Impact factor: 7.446

3.  Folate antagonists: toward improving the therapeutic index and development of new analogs.

Authors:  J R Bertino
Journal:  J Clin Pharmacol       Date:  1990-04       Impact factor: 3.126

Review 4.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 5.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

6.  Relationship between lipophilicity and binding affinity with human serum albumin for penicillin and cephem antibiotics.

Authors:  T Terasaki; H Nouda; A Tsuji
Journal:  J Pharmacobiodyn       Date:  1992-03

7.  Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level.

Authors:  J W Smit; E Duin; H Steen; R Oosting; J Roggeveld; D K Meijer
Journal:  Br J Pharmacol       Date:  1998-02       Impact factor: 8.739

8.  Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein.

Authors:  L J Bain; G A LeBlanc
Journal:  Toxicol Appl Pharmacol       Date:  1996-11       Impact factor: 4.219

9.  Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.

Authors:  M E Weinblatt; B N Weissman; D E Holdsworth; P A Fraser; A L Maier; K R Falchuk; J S Coblyn
Journal:  Arthritis Rheum       Date:  1992-02

10.  Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.

Authors:  G R Westerhof; J H Schornagel; I Kathmann; A L Jackman; A Rosowsky; R A Forsch; J B Hynes; F T Boyle; G J Peters; H M Pinedo
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

View more
  4 in total

Review 1.  Additional transporter characterization may lead to new pharmaceutical opportunities.

Authors:  O S Gudmundsson
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  A structure-activity relationship study of ABCC2 inhibitors.

Authors:  Gloria Wissel; Feng Deng; Pavel Kudryavtsev; Leo Ghemtio; Peter Wipf; Henri Xhaard; Heidi Kidron
Journal:  Eur J Pharm Sci       Date:  2017-02-07       Impact factor: 4.384

Review 3.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

4.  Prediction model of human ABCC2/MRP2 efflux pump inhibitors: a QSAR study.

Authors:  Minh-Tri Le; Thien-Vy Phan; Viet-Khoa Tran-Nguyen; Thanh-Dao Tran; Khac-Minh Thai
Journal:  Mol Divers       Date:  2020-02-11       Impact factor: 2.943

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.